Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

This publication has 31 references indexed in Scilit:

• Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action
  British Journal of Haematology, 1998
• Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses
  Blood Coagulation & Fibrinolysis, 1998
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
  New England Journal of Medicine, 1997
• TISSUE FACTOR PATHWAY INHIBITOR IN COMPLEX WITH LOW DENSITY LIPOPROTEIN ISOLATED FROM HUMAN PLASMA DOES NOT POSSESS ANTICOAGULANT FUNCTION IN TISSUE FACTOR-INDUCED COAGULATION IN VITRO
  Thrombosis Research, 1997
• Effect of Cholesterol Lowering on Intravascular Pools of TFPI and Its Anticoagulant Potential in Type II Hyperlipoproteinemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Tissue Factor Pathway Inhibitor
  Thrombosis and Haemostasis, 1995
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.
  Proceedings of the National Academy of Sciences, 1990
• Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor
  Nature, 1989
• Characterization of the inhibition of tissue factor in serum
  Blood, 1987
• Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously
  Thrombosis Research, 1983